
AB DigiHealth Inc. is a pioneering core laboratory advancing genomic research, originating from National Cheng Kung University in Taiwan. They specialize in maternal-fetal precision medicine, bridging scientific discoveries with clinical applications. Their offerings include AI-powered SaMD, specifically the intelligent cOmputing Noble Embryo (icONE), and genetic testing for preconception, prenatal, and newborn screening. The company leverages Next-Generation Sequencing (NGS), bioinformatics, and AI predictive algorithms to enhance prenatal genetic testing and establish a next-generation healthcare system focused on accuracy and efficiency.

AB DigiHealth Inc. is a pioneering core laboratory advancing genomic research, originating from National Cheng Kung University in Taiwan. They specialize in maternal-fetal precision medicine, bridging scientific discoveries with clinical applications. Their offerings include AI-powered SaMD, specifically the intelligent cOmputing Noble Embryo (icONE), and genetic testing for preconception, prenatal, and newborn screening. The company leverages Next-Generation Sequencing (NGS), bioinformatics, and AI predictive algorithms to enhance prenatal genetic testing and establish a next-generation healthcare system focused on accuracy and efficiency.